QUOTED. 2 August 2019. Bryan Hanson.
Zimmer Biomet says its long-term plan to return to steady growth is ahead of schedule. See what company CEO Bryan Hanson said about it here.
“We’ve increased accountability and strengthened our ‘ZB spirit’ across the organization as a result of our new structure, new leadership team and through a relentless focus on culture in connection to our mission. We continue to drive efficiency throughout our supply chain to ensure that we meet increased demand for our products and drive confidence in our sales team.” – Bryan Hanson, CEO, Zimmer Biomet Holdings Inc.
- Find out more: Zimmer Biomet Continues Turnaround Lead by ROSA Robot
Click here for a free trial of Medtech Insight